{{Rsnum
|rsid=1524107
|Gene=IL6
|Chromosome=7
|position=22728600
|Orientation=plus
|GMAF=0.2833
|Gene_s=IL6,MIR632
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 90.3 | 9.7 | 0.0
| HCB | 7.3 | 44.5 | 48.2
| JPT | 4.4 | 29.2 | 66.4
| YRI | 91.8 | 8.2 | 0.0
| ASW | 84.2 | 15.8 | 0.0
| CHB | 7.3 | 44.5 | 48.2
| CHD | 4.6 | 37.6 | 57.8
| GIH | 37.6 | 52.5 | 9.9
| LWK | 64.5 | 33.6 | 1.8
| MEX | 46.6 | 41.4 | 12.1
| MKK | 57.1 | 39.1 | 3.8
| TSI | 89.2 | 10.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto
|PMID=20186139
|Title=Interleukin-6 Receptor Gene Polymorphism Modulates Interleukin-6 Levels and the Metabolic Syndrome: GBCS-CVD
}}

{{PMID Auto
|PMID=22272811
|Title=Sequence variants of interleukin 6 (IL-6) are significantly associated with a decreased risk of late-onset Alzheimer's disease
|OA=1
}}

{{PMID|18496509|OA=1
}} An IL-6 haplotype on human chromosome 7p21 confers risk for impaired renal function in type 2 diabetic patients.

{{PMID|19267250|OA=1
}} C-reactive protein, interleukin-6, and prostate cancer risk in men aged 65 years and older.

{{PMID|19729864|OA=1
}} Association of genetic variation in serum amyloid-A with cardiovascular disease and interactions with IL6, IL1RN, IL1beta and TNF genes in the Cardiovascular Health Study.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}